These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 99877)

  • 1. Relationship between maternal anti-D levels, fetal phenotype and haemolytic disease of the newborn.
    Morley G
    Vox Sang; 1978; 35(5):324-31. PubMed ID: 99877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of discriminant analysis in relating maternal anti-D levels to the severity of haemolytic disease of the Newborn.
    Morley G; Gibson M; Eltringham D
    Vox Sang; 1977; 32(2):90-8. PubMed ID: 403679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-D concentration in mother and child in haemolytic disease of the newborn.
    Hughes-Jones NC; Ivona M; Ellis J; Walker W
    Vox Sang; 1971 Aug; 21(2):135-40. PubMed ID: 5000958
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus.
    Dooren MC; Engelfriet CP
    Vox Sang; 1993; 65(1):59-61. PubMed ID: 8362516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal-fetal hemorrhage: its incidence and sensitizing effects.
    Jennings ER; Clauss B
    Am J Obstet Gynecol; 1978 Aug; 131(7):725-7. PubMed ID: 99038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn.
    Zupańska B; Brojer E; Richards Y; Lenkiewicz B; Seyfried H; Howell P
    Vox Sang; 1989; 56(4):247-53. PubMed ID: 2503936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.
    Bowell P; Wainscoat JS; Peto TE; Gunson HH
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):327-9. PubMed ID: 6284295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
    Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
    Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between maternal HL-A immunization and familial prognosis of haemolytic disease of the newborn due to Rh incompatibility].
    Malinvaud G; Gualde N
    Rev Fr Transfus Immunohematol; 1975 Sep; 18(3):269-80. PubMed ID: 821129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous formation of carbon monoxide in newborn infants. II. Rh haemolytic disease of the newborn.
    Fällström SP; Bjure J
    Acta Paediatr Scand; 1967 Jul; 56(4):365-73. PubMed ID: 4962671
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of maternal anti-D concentration in predicting the outcome of Rh(D) haemolytic disease.
    Harrison KL; Baker JW; Popper EI; Harden PA
    Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):6-8. PubMed ID: 6430264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemolytic disease of the newborn due to antibodies other than rhesus anti-D.
    Br Med J (Clin Res Ed); 1981 Aug; 283(6290):514-5. PubMed ID: 6790046
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research on the passage of isohemagglutinins into milk in hemolytic disease of the newborn].
    Lange MM; Fiandino G
    Minerva Pediatr; 1967 Sep; 19(38):1728-34. PubMed ID: 4976636
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of RH antibodies in causing haemolytic disease of the newborn and in preventing it.
    Mollison PL
    J Clin Pathol; 1971 Jul; 24(5):479-80. PubMed ID: 4999068
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of the Rh-D antibody titres of amniotic fluids and corresponding maternal sera in Rh-D sensitized pregnancies.
    Usategui-Gomez M; Stearns S
    Nature; 1969 Jan; 221(5175):82-3. PubMed ID: 4973138
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-rhesus (D) blood group isoimmunization in obstetrics.
    Beal RW
    Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemolytic disease of the newborn due to Rhesus anti-e antibody.
    Chapman J; Waters AH
    Vox Sang; 1981; 41(1):45-7. PubMed ID: 6798758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Rh haemolytic disease.
    Clarke CA
    Nurs Mirror Midwives J; 1974 Oct; 139(17):57-9. PubMed ID: 4139694
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-D in a 'D positive' mother giving rise to severe haemolytic disease of the newborn. A dilemma in antenatal immunohaematological testing.
    Ostgård P; Fevang F; Kornstad L
    Acta Paediatr Scand; 1986 Jan; 75(1):175-8. PubMed ID: 3082104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rh and fetal erythroblastosis].
    Seixas AS; Plepis Júnior M; Werneck PS
    Hospital (Rio J); 1968 Jul; 74(1):207-12. PubMed ID: 4976965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.